Treating CLL with novel therapies

    Professor Peter Hillmen

    Advances in Immuno-Oncology

    Dr Robert Weinkove, Consultant Haematologist at Wellington Blood and Cancer Centre and Clinical Director at Malaghan Institute of Medical Research introduces the topic of immuno-oncology.  He discusses current and emerging classes of cancer immunotherapies and gives an overview of their mechanisms of action, current place in treatment and recognition of adverse effects in primary care.

    Extended Prevention of Recurrent VTE

    Speaker: Dr Gordon Royle

    In this recording of a live webcast event held in August 2020, Dr Royle addressed an audience of GPs and nurse practitioners on extended prevention of recurrent venous thromboembolism in primary care with a focus on the recommendations in the THANZ 2019 VTE Guidelines.

    Gordon Royle is a graduate of Otago Medical School. After moving to Auckland he undertook a Masters in Molecular Biology, and went on to train in Haematology. For the last 19 years he has been working as a Haematologist and researcher at Middlemore Hospital, and is a senior lecturer at Auckland University's School of Medicine. A particular interest is Coagulation Haematology. His clinical research experience includes the role of PI in several new oral anticoagulant trials. Prior research experience includes seven years' molecular biology in the USA including two years at The Salk Institute.